Gut-Derived Lipopolysaccharide Promotes T-Cell-Mediated Hepatitis in Mice through Toll-Like Receptor 4
Gut-Derived Lipopolysaccharide Promotes T-Cell-Mediated Hepatitis in Mice through Toll-Like Receptor 4
复制标题
肠道源性脂多糖通过 Toll 样受体 4 促进小鼠 T 细胞介导的肝炎
DOI:
10.1158/1940-6207.capr-11-0364
复制
发表时间:
2012-09-01
影响因子:
3.3
通讯作者:
Wang, Hong-Yang
中科院分区:
文献类型:
--
作者:
Lin, Yan;Yu, Le-Xing;Wang, Hong-Yang
Robust clinical and epidemiologic data support the role of inflammation as a key player in hepatocellular carcinoma (HCC) development. Our previous data showed that gut-derived lipopolysaccharide (LPS) promote HCC development by activating Toll-like receptor 4 (TLR4) expressed on myeloid-derived cells. However, the effects of gut-derived LPS on other types of liver injury models are yet to be studied. The purpose of this study was to determine the importance of gut-derived LPS and TLR4 signaling in a T-cell-mediated hepatitis-Con A-induced hepatitis model, which mimic the viral hepatitis. Reduction of endotoxin using antibiotics regimen or genetic ablation of TLR4 in mice significantly alleviate Con A-induced liver injury by inhibiting the infiltration of T lymphocytes into the liver and the activation of CD4(+) T lymphocytes as well as the production of T helper 1 cytokines; in contrast, exogenous LPS can promote Con A-induced hepatitis and CD4(+) T cells activation in vivo and in vitro. Reconstitution of TLR4-expressing myeloid cells in TLR4-deficient mice restored Con A-induced liver injury and inflammation, indicating the major cell target of LPS. In addition, TLR4 may positively regulate the target hepatocellular apoptosis via the perforin/granzyme B pathway. These data suggest that gut-derived LPS and TLR4 play important positive roles in Con A-induced hepatitis and modulation of the gut microbiotia may represent a new avenue for therapeutic intervention to treat acute hepatitis induced by hepatitis virus infection, thus to prevent hepatocellular carcinoma. Cancer Prev Res; 5(9); 1090-102. (c) 2012 AACR.